Literature DB >> 17579230

Does this patient have erythema migrans?

Carrie D Tibbles1, Jonathan A Edlow.   

Abstract

CONTEXT: Erythema migrans, while not pathognomonic, is the most common manifestation of early Lyme disease. Accurate diagnosis of this rash is essential to initiating appropriate antibiotic therapy.
OBJECTIVE: To determine the sensitivity of history and physical examination characteristics for the diagnosis of erythema migrans. DATA SOURCES: Structured MEDLINE searches of articles written only in English, 1966 through March 2007. STUDY SELECTION: Studies were included if they enrolled at least 15 consecutive patients with the diagnosis of erythema migrans and reported original data regarding the history and physical examination characteristics of the patients. DATA EXTRACTION: One author abstracted data from the studies.
RESULTS: We separately analyzed the studies from Europe and analyzed both Lyme-endemic and nonendemic areas of the United States to search for potential differences in the clinical presentation. Thirty-two studies from Europe, 20 studies from the United States, and 1 from Europe and the United States met inclusion criteria for a total of 8493 patients. Sensitivity was calculated for each of the variables. No studies included patients without erythema migrans, so specificity data and likelihood ratios could not be determined. Many patients do not recall a tick bite. Associated systemic symptoms, such as fever and headache, are frequently reported. Nausea and vomiting are rare. A solitary lesion is the most frequent presentation in both US (81%; 95% confidence interval [CI], 72%-87%) and European patients (88%; 95% CI, 81%-93%). Central clearing is less common in the endemic United States (19%; 95% CI, 11%-32%) vs Europe (79%; 95% CI, 69%-86%) and the nonendemic United States (80%; 95% CI, 63%-90%).
CONCLUSIONS: Our analysis of the current available literature suggests that there is no single element in the history or physical examination that is highly sensitive by itself for the diagnosis of erythema migrans. Clinicians should be aware of the wide variability in the clinical presentation of erythema migrans and the need to factor in multiple components of the clinical examination and epidemiological context.

Entities:  

Mesh:

Year:  2007        PMID: 17579230     DOI: 10.1001/jama.297.23.2617

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  45 in total

Review 1.  Lyme wars.

Authors:  Alison Tonks
Journal:  BMJ       Date:  2007-11-03

2.  Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.

Authors:  Susan C Lipsett; John A Branda; Alexander J McAdam; Louis Vernacchio; Caroline D Gordon; Catherine R Gordon; Lise E Nigrovic
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

3.  Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department.

Authors:  Lise E Nigrovic; Jonathan E Bennett; Fran Balamuth; Michael N Levas; Rachel L Chenard; Alexandra B Maulden; Aris C Garro
Journal:  Pediatrics       Date:  2017-12       Impact factor: 7.124

4.  Spatiotemporal evolution of erythema migrans, the hallmark rash of Lyme disease.

Authors:  Dhruv K Vig; Charles W Wolgemuth
Journal:  Biophys J       Date:  2014-02-04       Impact factor: 4.033

5.  Faces of Lyme.

Authors:  Debbie C Chen; Brandon M Giglio; Paul B Aronowitz
Journal:  J Gen Intern Med       Date:  2016-12-12       Impact factor: 5.128

6.  Expanding Access to Biospecimens for Lyme Disease Test Development.

Authors:  John L Schmitz
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 7.  Lyme Disease: What the Neuroradiologist Needs to Know.

Authors:  H A Valand; A Goyal; D A Melendez; S S Matharu; H S Mangat; R K Tu
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-31       Impact factor: 3.825

8.  Bacterial heterogeneity is a requirement for host superinfection by the Lyme disease spirochete.

Authors:  Artem S Rogovskyy; Troy Bankhead
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

9.  Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

Review 10.  Clinical practice. Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-05-01       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.